Group Post |
UK review finds COVID-19 shots do not raise risk of miscarriage |
mike kraft |
Group Post |
FDA head says agency could consider authorization for Covid-19 vaccine before Phase 3 trials are complete, Financial Times reports |
mike kraft |
Group Post |
The U.N.'s Covax is likely to deliver less than half of the promised 2 billion vaccine doses to help the world’s neediest icountries in 2021. |
mike kraft |
Group Post |
WHO extends public health emergency over Covid but signals end could come soon |
mike kraft |
Group Post |
Researchers Are starting Clinical Trials on a New Type Low-Cost Coronavirus Vaccine |
mike kraft |
Group Post |
Greenland ice losses set to raise global sea levels by nearly a foot--researh |
mike kraft |
Group Post |
Sanofi, GSK variant-specific COVID vaccine reported effective against Omicron |
mike kraft |
Group Post |
Opinion: Steps to rebuild trust in public health |
mike kraft |
Group Post |
Omicron now dominant strain of coronavirus in the U.S, 73% of new cases |
mike kraft |
Group Post |
Two new studies indicate Paxlovid's usefulness in helping prevent hospitalization, death in COVID outpatients |
mike kraft |
Group Post |
Global COVID-19 infection rate approaching highest of pandemic so far |
mike kraft |
Group Post |
New Zealand relaxes, Philippines continues Covid-19 countermeasures |
mike kraft |
Group Post |
An expert explains how to prepare for possible COVID-19 surge --CNN Analyst |
mike kraft |
Group Post |
EU drug watchdog urges COVID-19 vaccine update |
mike kraft |
Group Post |
Asia keeps omicron at bay for now, but worries about a surge that already hit Australia |
mike kraft |
Group Post |
Pfizer/BioNTech seeks U.S. nod for updated COVID vaccine as booster in kids under 5 |
mike kraft |
Group Post |
Why mask mandates for kids need to continue |
mike kraft |
Group Post |
Pfizer to supply up to 6 million COVID pill courses for lower income countries |
mike kraft |
Group Post |
US volunteers of various faiths working to help India counter coronavirus crisis |
mike kraft |
Group Post |
Merck says its COVID-19 pill works against variants--lab studies |
mike kraft |
Group Post |
Inovio lab tests show COVID vaccine weaker against Omicron, study focus to change |
mike kraft |
Group Post |
New frequency comb breathalyzer detects COVID-19 with excellent accuracy |
mike kraft |
Group Post |
A fourth Moderna covid shot may eventuallty be needed as efficacy of boosters likely to decline over time |
mike kraft |
Group Post |
Omicron XBB.1.16 subvariant cases rising in some countries--WHO |
mike kraft |
Group Post |
Florida: More than 10,000 COVID-19 variant cases, surge after spring break |
mike kraft |
Recent Comments